Tissue engineering and regenerative medicine (TERM) have been proposed and developed for more than 30 years. Although several successful attempts at tissue regeneration have been made, TERM is still in its infancy. There are many unanswered fundamental questions regarding the selection of cell sources, development of tissue-specific materials, specialized bioreactors, and the construction of complex organs. After all, most therapies or treatments aim to enhance tissue regeneration, and stem cell engineering has opened a new avenue in regenerative medicine. Tissue engineering can be applied to construct various tissues, including blood vessels, nerve tissues, skin, and bones. Several techniques involving new materials, new structures, and novel surface modifications of biomaterials are developed for stem cell engineering. Also, a deep understanding of the interactions between cells and biomaterials is needed. Advances in tissue engineering research and its methodology led to the formation of scaffolds for bioprinters and then to the decellularized organs. More research into processes is overcoming the shortcomings of previous methods. Improving knowledge in the biology of regeneration, development in microelectronics, and 3D printing technology helps overcome the hurdles. In additing, cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’s Kymriah was the first cell therapy solution offered for the treatment of B-cell acute leukemia, which opened opportunities for the emerging treatment therapy. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in pipeline, with three products—RCH-01, RCS-01, and RCT-01—in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of the products for various conditions, including diabetes, Hemophilia A, and hyperthyroidism. Therefore, rapid advancements in the development of regenerative medicines to provide effective solutions for chronic conditions are driving the growth of the market.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America tissue engineering market at a substantial CAGR during the forecast period.
South America Tissue Engineering Market Segmentation
The South America tissue engineering market is segmented on the basis of material type, application, and country. Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2021, the biologically derived materials segment held the largest market share. However, the synthetic materials segment is expected to register the highest CAGR during the forecast period. Based on application, the market is segmented into orthopedic, musculoskeletal & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi & gynecology, urology, and others. In 2021, the orthopedic, musculoskeletal, & spine segment held the largest market share. However, the skin & integumentary segment is expected to register the highest CAGR in the market during the forecast period. Based on country, the South America tissue engineering market is segmented into Brazil, Argentina, and Rest of SAM. In 2021, Brazil held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.
Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the South America tissue engineering market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 464.24 Million |
| Market Size by 2028 | US$ 913.73 Million |
| CAGR (2022 - 2028) | 10.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Material Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South America Tissue Engineering Market is valued at US$ 464.24 Million in 2022, it is projected to reach US$ 913.73 Million by 2028.
As per our report South America Tissue Engineering Market, the market size is valued at US$ 464.24 Million in 2022, projecting it to reach US$ 913.73 Million by 2028. This translates to a CAGR of approximately 10.2% during the forecast period.
The South America Tissue Engineering Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Tissue Engineering Market report:
The South America Tissue Engineering Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Tissue Engineering Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Tissue Engineering Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America Tissue Engineering Market
